No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Fixed-dose, subcutaneous injection of pertuzumab and trastuzumab is noninferior to intravenous administration in HER2⁺ breast cancer

byTeddy Guo

February 3, 2021

in StudyGraphics

Reading Time: 1 min read

Liver fibrosis in post-PCI patients associated with higher incidence of cardiovascular events

RelatedReports

Oophorectomy associated with reduced cancer risk and all-cause mortality for BRCA1/2 patients

Chronic Disease

Molecular-guided therapy improves survival in unfavorable cancer of unknown primary

December 3, 2024

No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer

Chronic Disease

Use of certain biologics or disease modifying antirheumatic drugs may be associated with cancer risk

November 30, 2024

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Gastroenterology

Fluorouracil, leucovorin and irinotecan plus panitumumab for the treatment of metastatic colorectal cancer

November 27, 2024

Medical vaccine exemptions increase after elimination of nonmedical exemptions

Weekly Rewinds

2 Minute Medicine Rewind November 25, 2024

November 25, 2024

Metabolic surgery may be more effective than medical therapy for long-term control of type 2 diabetes

#VisualAbstract: Novel hybrid closed-loop system improves glycemic control in young adults with type 1 diabetes

#VisualAbstract: Malaria Chemoprevention Improves Postdischarge Management of Severe Anemia

Isolated mild/moderate thrombocytopenia may not require intervention

Hypertension and obesity associated with changes in retinal microvasculature for children

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports